OSE Immunotherapeutics SA
LSE:0RAD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
O
|
OSE Immunotherapeutics SA
LSE:0RAD
|
FR |
|
M
|
Multikarya Asia Pasifik Raya Tbk PT
IDX:MKAP
|
ID |
|
Lotus Resources Ltd
ASX:LOT
|
AU |
|
Summerset Group Holdings Ltd
F:20S
|
NZ |
|
McDonald's Corp
NYSE:MCD
|
US |
|
Texas Roadhouse Inc
NASDAQ:TXRH
|
US |
|
M
|
Mitsubishi Chemical Group Corp
F:M3C0
|
JP |
|
I
|
Illumina Inc
SWB:ILU
|
US |
|
M
|
Metro Retail Stores Group Inc
XPHS:MRSGI
|
PH |
|
Denali Therapeutics Inc
NASDAQ:DNLI
|
US |
|
AAA Technologies Ltd
BSE:543671
|
IN |
|
W
|
Winpak Ltd
TSX:WPK
|
CA |
|
ING Groep NV
F:INNA
|
NL |
|
J
|
Jones Lang LaSalle Inc
SWB:4J2
|
US |
|
Wealth Minerals Ltd
XTSX:WML
|
CA |
|
SEB SA
PAR:SK
|
FR |
|
Sime Darby Bhd
OTC:SMEBF
|
MY |
|
C
|
CubeSmart
F:UK8
|
US |
Bankruptcy Probability
OSE Immunotherapeutics SA's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
OSE Immunotherapeutics SA Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| FR |
|
OSE Immunotherapeutics SA
PAR:OSE
|
47.8m EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
481.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
220.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
182.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
127.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
78.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
76.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
88B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
56.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
45.6B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
40.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
OSE Immunotherapeutics SA's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, OSE Immunotherapeutics SA has total debt of 32.5m EUR. This includes both short-term (0 EUR) and long-term (32.5m EUR) debt.
You can find a full breakdown on its Balance Sheet.